Employment and Support Allowance: Tumours

(asked on 5th February 2018) - View Source

Question to the Department for Work and Pensions:

To ask the Secretary of State for Work and Pensions, how many people with a brain tumour their main disabling condition have (a) applied for and (b) received Employment and Support Allowance in each year since 2010.


Answered by
Sarah Newton Portrait
Sarah Newton
This question was answered on 8th February 2018

Brain tumours can commonly refer to a range of different conditions depending on the type of tumour. They are also grouped with other central nervous system tumours when being recorded. As such it is not possible for us to isolate brain tumours as a separate recorded condition. The available information held relating to this condition is shown in the following tables:

Table 1: Number of individuals making an initial claim to Employment and Support Allowance (ESA) whose main disabling condition was recorded as relating to Brain or Central Nervous System Tumours, by year of claim start Jan 2010 to Mar 2017: Great Britain

Year of ESA claim start

Initial ESA
claims

2010

1,000

2011

1,200

2012

1,100

2013

1,200

2014

1,200

2015

1,100

2016

1,200

2017 (Jan - Mar)

300

Table 2: Number of individuals assigned to the ESA Support Group or the ESA Work Capability Group following their Work Capability Assessment (for initial, repeat or IB reassessment claims), whose main disabling condition was recorded as relating to Brain or Central Nervous System Tumours, by year of claim start or IB reassessment referral, Jan 2010 to Mar 2017: Great Britain

Year of ESA claim start

Initial ESA
claims

Repeat ESA
assessments

IB
reassessments

2010

800

400

-

2011

900

600

300

2012

900

600

600

2013

900

500

700

2014

900

300

100

2015

900

200

100

2016

800

100

100

2017 (Jan - Mar)

200

-

-

Source for Tables 1 and 2: Application data is derived from administrative data held by the DWP and assessment data provided by the Healthcare Provider.

Notes for Tables 1 and 2:

  1. The figures are rounded to the nearest 100. “–” denotes figures that are zero or less than 50.
  2. The information for 2017 is provided up to March 2017 only; this is the latest data available at time of request.
  3. National roll-out of IB reassessments began in March 2011. As a result, the 2011 figures for IB reassessment in Table 2 cover the period from March to December.
  4. An individual may have made more than one ESA claim or assessment in any given year. These individuals will only be counted once in each of the figures provided.
  5. The following groupings have been included in this analysis:

a. Malignant Neoplasm of Brain

b. Benign Neoplasm of Meninges

c. Benign Neoplasm of Brain and other parts of central nervous system

d. Neoplasm of uncertain or unknown behaviour of brain and central nervous system

6. The primary medical condition recorded on the claim form does not itself confer entitlement to ESA. So, for example, a decision on entitlement for a customer claiming ESA on the basis of Malignant Neoplasm of Brain would be based on their ability to carry out the range of activities assessed by the work capability assessment.

Reticulating Splines